Multiple Sclerosis (MS) Treatment Market By Drug Type (Immunomodulators, Immunosuppressants, Interferons, Corticosteroids and Others), By Patient Type (Relapsing-Remitting MS (RRMS), Primary Progressive MS (PPMS) and Secondary Progressive MS (SPMS)), By Route of Administration (Oral, Injectable and Intravenous (IV)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Specialty Pharmacies), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Nov 2024 | Report ID: MI1242 | 213 Pages

Report Summary Table of Contents Segmentation FAQ Request Free Sample Report

Report Coverage:

By Drug Type

  • Immunomodulators
  • Immunosuppressants
  • Interferons
  • Corticosteroids
  • Others

By Patient Type

  • Relapsing-Remitting MS (RRMS)
  • Primary Progressive MS (PPMS)
  • Secondary Progressive MS (SPMS)

By Route of Administration

  • Oral
  • Injectable
  • Intravenous (IV)

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Specialty Pharmacies

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa

List of Companies:

  • Biogen Inc.
  • Novartis AG
  • Sanofi Genzyme
  • Roche Holding AG
  • Merck KGaA
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly and Company
  • Bristol-Myers Squibb
  • AbbVie Inc.
  • Sandoz
  • Horizon Therapeutics
  • Celgene
  • Acorda Therapeutics, Inc.
  • Allergan
  • Pfizer Inc.

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.

Request Bundle Pricing